Argumentation Analysis of Risk Assessments: The Case of Perfluorooctanoic Acid.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Argumentation Analysis of Risk Assessments: The Case of Perfluorooctanoic Acid.Published in
Risk Anal 2022; 42(4):770-785PMID
34296455ae974a485f413a2113503eed53cd6c53
10.1111/risa.13793
Scopus Count
Collections
Related articles
- Reasoning on conflicting information: An empirical study of Formal Argumentation.
- Authors: Guillaume M, Cramer M, van der Torre L, Schiltz C
- Issue date: 2022
- The Effects of General Practitioners' Use of Argumentation to Support Their Treatment Advice: Results of an Experimental Study Using Video-Vignettes.
- Authors: Labrie NH, Schulz PJ
- Issue date: 2015
- Does argumentation matter? A systematic literature review on the role of argumentation in doctor-patient communication.
- Authors: Labrie N, Schulz PJ
- Issue date: 2014
- "Doctors Killed My Baby": Argumentative Patterns in Medical Disputes in China.
- Authors: Pan D
- Issue date: 2018 Oct
- Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.
- Authors: Negri E, Metruccio F, Guercio V, Tosti L, Benfenati E, Bonzi R, La Vecchia C, Moretto A
- Issue date: 2017 Jul